Immunoassays

Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.

Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

Der Varicella-Zoster Virus (VZV) IgA ELISA ist für den qualitativen Nachweis spezifischer IgA-Antikörper gegen Varicella-Zoster Virus (VZV) in humanem Serum oder Plasma (Citrat, Heparin) bestimmt.

The Avidity Epstein-Barr Virus (VCA) IgG ELISA is intended to indicate the Epstein-Barr virus viral capsid antigen (VCA)-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Measles Virus IgG ELISA is intended to indicate the Measles-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Ascaris lumbricoides IgG ELISA is intended for the qualitative determination of IgG class antibodies against Ascaris lumbricoides in human serum or plasma (citrate, heparin).

The Aspergillus fumigatus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Aspergillus fumigatus in human serum or plasma (citrate, heparin).